UOB Kay Hian Research sees stock market consolidating in 3Q

TheStar Fri, Jul 10, 2020 10:40am - 3 years View Original


Duopharma Biotech products on display. The company is among the mid-cap stocks favoured by UOB Kay Hian Malaysia Research.

KUALA LUMPUR: UOB Kay Hian Malaysia Research expects the stock market to move into a consolidation mode following a spectacular recovery into a bull territory from a global Covid-19 outbreak-induced bear market.

“We expect sentiment in 3Q20 to be affected by a poor economic recovery and consumption, sharply reduced retail investor participation, and internal political bickering, ” it said in its strategy outlook on Friday.

Its strategy prescription is to immunise the portfolio with financially resilient or growth stocks and/or sustain generous dividends.

...

Full Article on TheStar

The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.






Related Stocks

BAT 8.250
DPHARMA 1.190
GENM 2.650
GENTING 4.580
GTRONIC 1.260
KOSSAN 2.110
MRCB 0.685
PPB 15.880
SCIENTX 4.130
SENTRAL 0.795
TENAGA 11.860
TOPGLOV 0.850
YINSON 2.390

Comments

Login to comment.